Online program to support breast cancer patients with lifestyle changes
Official title: DianaWeb: Before and After Study Online Based Participatory Research to Test Whether Lifestyle and Diet Are Able to Reduce the Incidence of Recurrences (Local, Remote) or Secondary Cancers, Improve Prognosis and Survival of Breast Cancer
Run by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT05057598 · Data updated 2026-11-12
This study is testing an online program to help breast cancer survivors in Italy make healthy lifestyle changes to see if it can improve their chances of staying well and feeling better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | Women only |
| Enrollment | 50000 (estimated) |
| Sponsor | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Milan, MI) |
| Status | Recruiting |
| Started | June 21, 2016 |
| Main results expected | December 31, 2023 |
| Study ends | December 31, 2028 |
| Registry record updated | September 27, 2021 |
| Trial ID | NCT05057598 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women diagnosed with breast cancer, including those with relapses or metastases, regardless of how long ago their initial diagnosis was.
✕Probably not a fit
Patients with a clinical diagnosis of Alzheimer's Disease or dementia, or those unable to use a personal computer or smartphone, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
DianaWeb is a community-based participatory research initiative aimed at Italian women diagnosed with breast cancer. The program evaluates the effectiveness of lifestyle and nutrition interventions to improve patient prognosis through an interactive website that monitors lifestyle choices and collects clinical data. Participants receive evidence-based information and practical advice to encourage healthy lifestyle changes based on established cancer prevention guidelines. The study aims to recruit 50,000 breast cancer survivors to assess the impact of these interventions on recurrence and quality of life.
Why it matters
Potential benefit: If successful, this program could significantly improve the prognosis and quality of life for breast cancer patients through sustainable lifestyle changes.
How similar studies have gone: Other studies have shown success with similar lifestyle intervention approaches for cancer patients, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with breast cancer diagnosis * Women with breast cancer relapses * Women with breast cancer metastases * Women with breast cancer diagnosis even if many years have elapsed since the first diagnosis * Women with breast cancer diagnosis and other tumors diagnosis * Women with breast cancer diagnosis and other pathologists that impair cognitive abilities Exclusion Criteria: * Women with breast cancer diagnosis and clinical diagnosis of Alzheimer's Disease * Women with breast cancer diagnosis and clinical diagnosis of dementia * Women with breast cancer diagnosis unable to use personal computer and smart phone
Where it's running
-
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Mi, Italy Recruiting
Study contacts
- Principal investigator: ANNA VILLARINI, PhD — Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
- Study coordinator: ANNA VILLARINI, PhD
- Email: anna.villarini@istitutotumori.mi.it
- Phone: +390223903552
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.